Benign neoplasm of mediastinum

Summary

Benign neoplasm of mediastinum (MONDO:0021521) is a cancer. A subtype of thoracic benign neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	benign neoplasm of mediastinum
Mondo ID	MONDO:0021521
ICD-10-CM	D15.2
ICD-11	1337535393
NCIT	C3604
SNOMED CT	92214000
UMLS	C0153956
MedGen	102298
Anatomy (UBERON)	UBERON:0003728
Is cancer (heuristic)	yes

Also known as: benign mediastinal neoplasm · benign mediastinal tumor · benign mediastinal tumour · benign neoplasm of the mediastinum · benign tumor of mediastinum · benign tumor of the mediastinum · benign tumour of mediastinum · benign tumour of the mediastinum · mediastinum benign neoplasm

Disease family

This is a subtype of thoracic benign neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › benign neoplasm › thoracic benign neoplasm › benign neoplasm of mediastinum

Related subtypes (7): breast benign neoplasm, lung benign neoplasm, benign neoplasm of heart, benign neoplasm of sternum, benign neoplasm of pericardium, benign neoplasm of chest wall, benign axillary neoplasm

Subtypes (2): mediastinum leiomyoma, mediastinal schwannoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.